[Finometer]

The newest addition to our sophisticated range of technologies is the highly accurate and reliable blood pressure measuring device, the Finometer.Our Research Director, Dr Radivoj Arezina, MD MSc, commented “Our new Finometer compliments our expanding range of highly sophisticated equipment. The device not only allows continuous measurement of blood pressure in a particularly thorough and scientific manner, but also stores information and converts it into a range of user friendly formats to enable accurate analysis of the waveform. The impact this type of technology has on clinical studies is considerable; we now provide rapid, wide ranging and definitive analysis on the effect of drugs on arterial blood pressure.”The instrument includes Beatscope PC-based software and allows almost complete non-invasive characterisation of the arterial circulation and its beat-to-beat variability in pressure and flow. The new device is able to measure systolic, diastolic and true mean arterial pressure, heart rate, interbeat interval, left ventricular ejection time, stroke volume, cardiac output, systemic peripheral resistance and a time-tension index.

Latest news

Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology

December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event